1 Turkistanli E C,Sogukpinar N,Saydam B K,et al. Cervical cancer prevention and early detection--the role of nurses and midwives.[J]. Asian Pac J Cancer P,2016,4(1):15-21. 2 Chelmow D. Cervical cancer screening and prevention[J]. Obstet Gynecol,2016,127(1):e1-e20. 3 Malo T L,Perkins R B,Lee J H,et al. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination[J]. Sex Transm Dis,2016,43(7):438-444. 4 Zhou L L,Shen Y,Gong J M,et al. MicroRNA-466 with tumor markers for cervical cancer screening[J]. Oncotarget,2017,8(41):70821. 5 Wang X J,Qin S,Wang Y M,et al. Value and significance of tumor markers as CEA,CA125,SCC-Ag,CA199 and CYFRA21-1in diagnosis of cervical cancer[J]. J Hainan Medical University,2017,23(18):132-135. 6 Schiffman M,Wentzensen N,Khan M J,et al. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines.[J]. J Low Genit Tract Dis,2017,21(2):87. 7 Rijal P,Pradhan T,Agrawal A,et al. Assessment of Risk Factors,Feasibility and Acceptability of VIA for Cervical Cancer Screening and Prevention[J]. Nepal J Obstet Gynaecol,2016,11(1):54. 8 陈娇,孔为民. 宫颈癌筛查方法的现状与研究进展[J]. 医学综述,2016,22(12):2338-2342. 9 赵同香,邓小虹,韩历丽. 宫颈癌筛查状况及评价指标研究进展[J]. 中华疾病控制杂志,2013,17(8):715-717. 10 Zutshi V,Dankher S,Malik A. Cervical Cancer Screening and Prevention: An Analysis of Beliefs and Predictors of Knowledge,Attitude and Practice in Northern India[J]. Indian J Gynecol Oncol,2017,15(4):71. 11 颜萍,龚旭华. 多种血清肿瘤标志物检测在早期宫颈癌诊断中的意义[J]. 实用癌症杂志,2014,29(7):741-743. 12 祁璘,李莉,琪美格,等. 肿瘤标志物检测在宫颈癌诊断中的应用探讨[J]. 重庆医学,2017,46(31):4425-4427. 13 朱茜,刘岿然,邓新. 血清鳞状细胞癌抗原和癌胚抗原及癌抗原125联合检测在宫颈癌诊断中的临床意义[J]. 中国综合临床,2013,29(6):646-648. 14 周炳辉,张春访. 宫颈癌患者血清SCC、CYFRA21-1、CA125、CEA联合检测的临床意义.[J]. 现代中西医结合杂志,2014,23(13):1453-1454. 15 Farzaneh F,Shahghassempour S,Noshine B,et al. Application of tumor markers SCC-Ag,CEA,and TPA in patients with cervical precancerous lesions[J]. Asian Pac J Cancer P,2014,15(9):3911-4. 16 熊樱,梁立治,郑敏,等. 血清CYFRA21-1与宫颈癌患者临床病理特征及预后的关系[J]. 实用妇产科杂志,2011,27(9):674-677. 17 闫慧,薛冰. 血清肿瘤标志物CA125、CEA联合检测在宫颈癌诊断中的临床价值[J]. 国际检验医学杂志,2016,37(1):134-135. 18 张蕾,曾凡清. 血清中SCC-Ag、CEA和CA125联合检测在宫颈癌诊断中的意义[J]. 中国实验诊断学,2017,21(10):1708-1710. 19 陈红军. 血清中SCC、CEA、CA125与CA19-9检测在早期宫颈癌诊断中的意义[J]. 河南医学研究,2017,26(3):457-458. 20 Liu Y,Zhang L,Zhao G,et al. The clinical research of Thinprep Cytology Test (TCT) combined with HPV-DNA detection in screening cervical cancer.[J]. Cell mol biol (Noisy-le-Grand,France),2017,63(2):92. |